Cystic Fibrosis Patient Registries: Domestic and Foreign Experience
Cystic fibrosis is a multi-organ genetic disease that reduces life expectancy and requires costly complex therapy. The economic burden of cystic fibrosis is determined by the cost of treatment, the conditions for optimizing medical technologies based on epidemiological knowledge of the disease cours...
Saved in:
Main Authors: | Dmitry A. Andreev, Ekaterina E. Bashlakova, Natalia V. Khachanova, Maria V. Davydovskaia |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Union of pediatricians of Russia
2017-08-01
|
Series: | Педиатрическая фармакология |
Subjects: | |
Online Access: | https://www.pedpharma.ru/jour/article/view/1512 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Cystic Fibrosis Newborn Screening and Follow-Up Process in Georgia (2022–2023)
by: Nino Vardosanidze, et al.
Published: (2025-06-01) -
Quantitative ultrasound rating of liver fibrosis in children with cystic fibrosis
by: G. M. Dvoryakovskaya, et al.
Published: (2014-08-01) -
The Effect of Aminoglycoside Use on the Hearing of Children with Cystic Fibrosis
by: Mehmet Mustafa Özaslan, et al.
Published: (2025-06-01) -
Exercise Prescription in Lung-Transplanted Cystic Fibrosis Adults
by: Melissa Orlandi, et al.
Published: (2025-06-01) -
Trends in Life Expectancy of Cystic Fibrosis Patients in Moscow and their Connection with the Treatment Received: Retrospective Analysis for 1993–2013
by: N. Yu. Kashirskaya, et al.
Published: (2015-09-01)